Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Feb 27, 2024; 16(2): 146-151
Published online Feb 27, 2024. doi: 10.4254/wjh.v16.i2.146
Changes in the etiology of liver cirrhosis and the corresponding management strategies
Jin-Jin Dai, Yue-Ying Liu, Zhen-Hua Zhang
Jin-Jin Dai, Department of Infectious Diseases, Suzhou Hospital of Anhui Medical University, Suzhou 234000, Anhui Province, China
Jin-Jin Dai, Yue-Ying Liu, Zhen-Hua Zhang, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, Anhui Province, China
Author contributions: Dai JJ and Liu YY contributed to this paper; Zhang ZH designed the overall concept and outline of the manuscript; Liu YY contributed to the discussion and design of the manuscript; Dai JJ contributed to the writing, and editing the manuscript, illustrations, and review of literature.
Supported by Anhui Provincial Natural Science Foundation, No. 2108085MH298; University Scientific Research Project of Anhui Provincial Education Department, No. KJ2021A0323; Fund of Anhui Medical University, No. 2021xkj196; and Clinical Medicine Project of Anhui Medical University, No. 2021LCXK027.
Conflict-of-interest statement: The authors declare that they have no conflicts of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhen-Hua Zhang, MD, PhD, Professor, Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei 230601, Anhui Province, China. zzh1974cn@163.com
Received: December 10, 2023
Peer-review started: December 10, 2023
First decision: January 15, 2024
Revised: January 16, 2024
Accepted: January 30, 2024
Article in press: January 30, 2024
Published online: February 27, 2024
Core Tip

Core Tip: China is aiming to eradicate viral hepatitis as a public health threat by 2030. It is expected that the prevalence of viral hepatitis will decrease in the coming years. The increasing prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) may emerge as a leading cause of liver cirrhosis. Additionally, excessive alcohol consumption is a significant risk factor. These shifting trends necessitate innovative management strategies. There is a need for sustained implementation of measures to eliminate viral hepatitis, as well as greater efforts to control obesity, diabetes and alcohol consumption to reduce the incidence of MASLD and Alcoholic liver disease.